These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33303053)
1. Cyclodextrin related drug delivery system to promote atherosclerosis regression. Zhang L Pharmazie; 2020 Dec; 75(12):619-625. PubMed ID: 33303053 [TBL] [Abstract][Full Text] [Related]
3. Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory "Prodrug". Mendelsohn AR; Larrick JW Rejuvenation Res; 2016 Jun; 19(3):252-5. PubMed ID: 27241174 [TBL] [Abstract][Full Text] [Related]
4. A ROS-responsive multifunctional targeted prodrug micelle for atherosclerosis treatment. Zhou Z; Liu Y; Xie P; Yin Z Int J Pharm; 2024 Jul; 660():124352. PubMed ID: 38901540 [TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis. Wang Y; Gao H; Huang X; Chen Z; Kang P; Zhou Y; Qin D; Zhang W; Liu J Carbohydr Polym; 2022 Sep; 292():119632. PubMed ID: 35725197 [TBL] [Abstract][Full Text] [Related]
6. Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells. He J; Yang Y; Zhou X; Zhang W; Liu J J Mater Chem B; 2020 Feb; 8(7):1496-1506. PubMed ID: 31999290 [TBL] [Abstract][Full Text] [Related]
7. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment. Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519 [TBL] [Abstract][Full Text] [Related]
17. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics. Gu L; Faig A; Abdelhamid D; Uhrich K Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069 [TBL] [Abstract][Full Text] [Related]
18. Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway. Hu Y; Sun B; Liu K; Yan M; Zhang Y; Miao C; Ren L Inflammation; 2016 Feb; 39(1):228-236. PubMed ID: 26307750 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation. Karagiannis AD; Liu M; Toth PP; Zhao S; Agrawal DK; Libby P; Chatzizisis YS Curr Atheroscler Rep; 2018 Mar; 20(4):20. PubMed ID: 29525934 [TBL] [Abstract][Full Text] [Related]
20. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk]. Yoshida H Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]